康恩贝：关于苓桂术甘汤颗粒获得药品注册证书的公告

Group 1 - The core point of the article is that Kang En Bei has received approval from the National Medical Products Administration for the drug registration certificate of Ling Gui Zhu Gan Decoction Granules [2] Group 2 - The approval signifies a regulatory milestone for the company, potentially enhancing its product portfolio in the pharmaceutical market [2] - The announcement was made on the evening of September 3, indicating a timely update for stakeholders [2] - This development may lead to increased market opportunities and revenue growth for the company in the future [2]